ArticleInternational medical case reports journal2026
Severe Acute Liver Injury Following Repeated Supratherapeutic Paracetamol Ingestion in a Child: A Case Report from a Resource-Limited Setting.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Paracetamol is commonly used in children and is generally considered safe when given at recommended doses. However, repeated supratherapeutic ingestion over several days can lead to acute liver injury that develops gradually and presents with nonspecific symptoms, making early recognition difficult, particularly in resource-limited settings. Case Presentation: We describe a previously healthy two-year-old boy who presented with vomiting, abdominal pain, and lethargy after a recent febrile illness. Caregiver history revealed that paracetamol syrup had been given every two hours for three consecutive days to control persistent fever. This resulted in an estimated daily dose of 103 mg/kg and a cumulative dose of 309 mg/kg. Laboratory evaluation at presentation showed severe hepatocellular injury with alanine aminotransferase 3760 U/L, aspartate aminotransferase 3240 U/L, total bilirubin 8.9 mg/dL, direct bilirubin 4.8 mg/dL, prothrombin time 20 seconds, and international normalized ratio 1.9. Serum paracetamol concentration was unavailable. Based on the clinical history and biochemical findings, intravenous N-acetylcysteine therapy was started promptly. Liver tests worsened transiently during hospitalization, improved by discharge, and normalized by six-week follow-up. Conclusion: This case demonstrates that repeated dosing of paracetamol beyond recommended limits can result in severe liver injury in children. It highlights the importance of obtaining a careful medication history, recognizing the limitations of serum drug levels in such situations, and starting N-acetylcysteine promptly when repeated supratherapeutic ingestion is suspected. It also reinforces the need to improve caregiver awareness of safe dosing practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.